Close

UPDATE: BMO Capital Downgrades Akcea Therapeutics, Inc. (AKCA) to Market Perform

Go back to UPDATE: BMO Capital Downgrades Akcea Therapeutics, Inc. (AKCA) to Market Perform
(NASDAQ: AKCA) Delayed: 18.17 --0 (-0%)
Previous Close $18.17    52 Week High
Open $22.77    52 Week Low
Day High $18.17    P/E N/A 
Day Low $18.17    EPS
Volume 2,023